Neuland Laboratories schedules analyst meetings in Hyderabad
- Neuland Laboratories schedules group investor meetings on September 15 and 17, 2026
- Events include Emkay Global Investors Meeting and ICICI Securities Healthcare Day
- Both meetings will be held in Hyderabad
- Schedule is subject to change per SEBI Regulation 30 disclosure

*this image is generated using AI for illustrative purposes only.
Neuland Laboratories Limited has scheduled two group meetings with analysts and institutional investors in Hyderabad later this month.
The company issued the intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The schedule is subject to change based on participant availability.
Meeting Schedule
The management team will participate in the following events:
| Date | Event Name | Location | Type |
|---|---|---|---|
| September 15, 2026 | Emkay Global Investors Meeting | Hyderabad | Group meet |
| September 17, 2026 | ICICI Securities - Hyderabad Healthcare Day | Hyderabad | Group meet |
Sarada Bhamidipati, Company Secretary, signed the disclosure dated September 9, 2026.
Historical Stock Returns for Neuland Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.11% | +2.82% | +5.94% | +86.83% | +58.99% | 0.0% |
What specific strategic initiatives or pipeline developments is Neuland Laboratories likely to highlight during the Hyderabad Healthcare Day?
How might investor sentiment from these group meetings influence Neuland's stock valuation in the short term?
Are there any upcoming regulatory approvals or clinical trial results for Neuland's key products that investors will be pressing management on?


































